AnnouncementsGranules India: Outcome of EGM
AnnouncementsGranules announces acquisition of Auctus Pharma
AnnouncementsGranules India: Outcome of board meeting
AnnouncementsGranules India to close its Singapore subsidiary
AnnouncementsGranules India: Updates on outcome of AGM
AnnouncementsGranules India: Outcome of AGM
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.36||2545.00||1764.00||41,197.31|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Granules India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 367.06 crore.The company has reported a consolidated sales of Rs 266.05 crore and a Net Profit of Rs 15.11 crore for the quarter ended Sep 2013.
The company management includes C Nageswara Rao - Chairman, C Krishna Prasad - Managing Director, L S Sarma - Director, A P Kurian - Director, C Parthasarathy - Director, Krishna Murthy Ella - Director, Arun Rao Akinepally - Director, Harsha Chigurupati - Executive Director, Uma Chigurupati - Executive Director, K B Sankara Rao - Additional Director.
It is listed on the BSE with a BSE Code of 532482 and the NSE with an NSE Code of GRANULES.
Its Registered office is at 2nd Floor, 3rd Block,,My Home Hub, Hyderabad,Andhra Pradesh - 500081.
Their Registrars are Cil Securities Ltd.